Welcome to our dedicated page for Selectquote news (Ticker: SLQT), a resource for investors and traders seeking the latest updates and insights on Selectquote stock.
SelectQuote, Inc. (NYSE: SLQT) is described in its public communications as a leading distributor of Medicare insurance policies and the owner of a rapidly growing healthcare services platform. News about SLQT often centers on its SelectQuote Senior Medicare distribution business, its Healthcare Services segment anchored by the SelectRx pharmacy, and its SelectQuote Life insurance operations.
On this page, readers can follow company announcements about Medicare insurance distribution performance, healthcare services initiatives and capital structure developments. Recent releases have highlighted new credit facilities arranged with lenders, including a senior secured term loan and revolving credit facility used to refinance existing debt and support working capital. Other news has focused on multiyear agreements for SelectRx with pharmacy benefit manager partners aimed at providing more predictable reimbursement economics.
Company news also covers operational metrics and research from its Healthcare Services platform. SelectQuote has reported on SelectRx membership growth, prescriptions shipped per day, and research from its Healthcare Select division that examines chronic conditions, prescription use, social determinants of health and medication adherence among Medicare beneficiaries. Additional updates describe partnerships with social service platforms to connect low-income seniors with food, housing, transportation and other support programs.
Investors and observers can use this news feed to review earnings releases, segment results for Senior, Healthcare Services and Life, updates on Medicare Advantage policy volumes, and disclosures about new programs designed to improve medication adherence for polychronic Medicare beneficiaries. Regularly reviewing SLQT news provides context on how the company’s insurance distribution and healthcare services ecosystem is evolving over time.
SelectQuote (NYSE: SLQT) announced SelectQuote Local, a franchise channel to sell senior health and life insurance through local representatives while leveraging the company’s marketing, technology, carrier relationships, and customer service.
The company said the model requires low capital from the company, aims to generate recurring royalty revenue, and complements its SelectRx pharmacy and healthcare services and a recently finalized $415 million credit facility.
SelectQuote (NYSE: SLQT) said CEO Tim Danker and CFO Ryan Clement will participate in the Mizuho 2026 Virtual Healthcare Technology Conference on March 5, 2026. Management will be available for one-on-one and small group investor meetings.
SelectQuote (NYSE: SLQT) reported Q2 FY2026 consolidated revenue of $537.1 million, net income of $69.3 million and consolidated Adjusted EBITDA of $84.7 million. Fiscal 2026 guidance: revenue of $1.61B–$1.71B and Adjusted EBITDA of $90M–$100M. Segment highlights: Senior revenue $261.5M (Adj. EBITDA $102.5M), Healthcare Services revenue $230.7M (Adj. EBITDA $0.8M), and Life revenue $43.6M. SelectRx membership reached 113,483, up 17% year-over-year.
SelectQuote (NYSE: SLQT) will release its fiscal second quarter 2026 results before market open on Thursday, February 5, 2026. CEO Tim Danker and CFO Ryan Clement will host a conference call and live webcast on February 5, 2026 at 8:00 AM ET to discuss the results.
Investors can access the live webcast on the company investor relations website and must register to receive dial-in details and unique entry codes; registration is open through the live call but early registration is recommended.
SelectQuote (NYSE: SLQT) highlighted a University of Kansas study (Jan 21, 2026) showing e-brokers expand Medicare Advantage access in 10 rural states. The study found ~400,000 residents live in counties without a local licensed Medicare broker and that broker coverage is thin in rural, lower‑income counties. SelectQuote offers Medicare Advantage plans in nearly every county across the ten states studied and its active membership base skews about 45% more rural than the national Medicare Advantage distribution. The research also found SelectQuote over-indexes in lower median income counties and generally offers a broader range of plans in those areas.
SelectQuote (NYSE: SLQT) announced a new multiyear agreement between its SelectRx pharmacy and a significant, long-time PBM partner that took effect on January 1, 2026. The company says the contract provides greater predictability and stability in reimbursement rates, which management links to its fiscal 2026 first-quarter outlook and to its ability to invest in SelectRx. SelectRx serves more than 100,000 Medicare members across all 50 states from three pharmacy facilities in Pennsylvania, Indiana, and Kansas. The company also referenced a recent capital structure refinancing with Pathlight and UMB to support operations and cash-flow focus.
SelectQuote (NASDAQ:SLQT) announced a $415,000,000 senior secured credit facility with Pathlight Capital serving as Administrative Agent on Jan 13, 2026. As part of the financing, Pathlight underwrote and provided a $325,000,000 term loan. Proceeds will be used to refinance existing debt and to support ongoing working capital needs. Company commentary says the funding lowers its cost of capital, improves liquidity and provides capital flexibility to invest in its senior health insurance and healthcare services businesses. Pathlight described the transaction as an example of its asset-based financing for specialty finance assets.
SelectQuote (NYSE: SLQT) closed a new $415 million credit package on January 12, 2026: a $325 million term loan from Pathlight Capital and an enhanced $90 million revolving facility with UMB Bank. Proceeds repaid prior term debt due June 2026 and September 2027 and extend term debt maturity to January 2031. The revolver increases seasonal capacity from $72M to $90M, the term loan reduces principal amortization and the deal includes up to 100 bps future interest-step downs, improving liquidity and cost of capital.
SelectQuote (NYSE: SLQT) reported Q1 FY2026 revenue $328.8M versus $292.3M a year ago and a net loss $30.5M. Consolidated Adjusted EBITDA $(32.1)M compared with $(1.7)M in prior-year quarter. Management reaffirmed fiscal 2026 guidance of $1.65–$1.75B revenue and $120–$150M Adjusted EBITDA. Segment moves: Healthcare Services revenue $221.4M (+42%) and Adjusted EBITDA $7.2M; Senior revenue $59.0M (-37%) and Adjusted EBITDA $(21.0)M; Life revenue $46.6M (+19%) and Adjusted EBITDA $5.6M.
Key operating metrics: 106,914 SelectRx members, approved Medicare Advantage policies 62,510, and a rolling revenue/CAC 6.4x.
SelectQuote (NYSE: SLQT) will release its fiscal first quarter 2026 results before market open on Thursday, November 6, 2025. CEO Tim Danker and CFO Ryan Clement will host a conference call the same day at 8:30 AM ET to discuss results. Registration is required for call access and will provide dial-in details and unique entry codes; registration is open through the live call but investors are advised to register at least one day in advance or 10 minutes before the call. The event will be webcast live on the company investor relations website with replay availability as provided on the site.